Keyphrases
Hepatitis C Virus
100%
Hepatitis C
39%
Hepatitis C Virus Infection
39%
Viroid
35%
Hepatocellular Carcinoma
32%
AIDS/HIV
29%
Liver
26%
Hepatitis C Treatment
24%
Sustained Virological Response
24%
Liver Transplantation
23%
Hepatitis C Virus RNA
23%
Telaprevir
20%
Potato Spindle Tuber Viroid (PSTVd)
20%
Confidence Interval
19%
Primary Biliary Cirrhosis
18%
Ribozyme
18%
Core Genes
18%
Cirrhosis
16%
Odds Ratio
16%
Infected Patients
16%
Liver Transplant Recipients
16%
Liver Fibrosis
16%
Triple Therapy
15%
Hepatitis delta Virus
15%
Enkephalin
15%
Sofosbuvir
15%
Risk Factors
15%
Ribavirin
15%
Liver Disease
14%
Hepatic Steatosis
13%
Interferon-α (IFN-α)
13%
Chronic Hepatitis C Virus Infection
13%
Chronic Hepatitis C
13%
Vitamin D Deficiency
12%
Hepatocellular Carcinoma Surveillance
12%
Advanced Fibrosis
12%
Response Rate
12%
Antisense
11%
Hepatitis C Virus Core
11%
HIV Infection
11%
Non-alcoholic Fatty Liver Disease (NAFLD)
11%
Fibrosis
11%
Co-infected Patients
10%
Steatosis
10%
Local Tertiary Structure
9%
Genotype 1
9%
Tenofovir
9%
Pre-exposure Prophylaxis (PrEP)
9%
Vitamin D
9%
Reading Frame
9%
Medicine and Dentistry
Hepatitis C
64%
Hepatitis C Virus
62%
Human Immunodeficiency Virus
37%
Hepatocellular Carcinoma
36%
Liver Graft
22%
Fibrosis
17%
Primary Biliary Cirrhosis
15%
Sofosbuvir
15%
Antivirus Agent
15%
Interferon
14%
Liver Transplantation
14%
Telaprevir
14%
Liver Fibrosis
14%
Odds Ratio
13%
Liver Cirrhosis
13%
Prevalence
12%
Antisense
12%
Chronic Hepatitis C
12%
Infection
12%
Ribavirin
12%
Liver Disease
12%
Decompensated Liver Cirrhosis
11%
Steatosis
10%
Vitamin D
9%
Hepatitis B
9%
COVID-19
9%
Disease
9%
Immunity
9%
Adverse Event
8%
Fatty Liver
8%
Nonalcoholic Fatty Liver
7%
Neoplasm
7%
Mixed Infection
7%
Recurrent Disease
7%
Transplantation
6%
Antiviral Therapy
6%
Electronic Patient Record
6%
Peginterferon
6%
Biological Marker
6%
Immigrant
6%
Patient-Reported Outcome
6%
Programmed Death 1 Receptor
6%
Multiple Myeloma
6%
Tenofovir
6%
Prospective Study
6%
Monoclonal Gammopathy of Undetermined Significance
6%
Gene Linkage
6%
Low Drug Dose
6%
Retreatment
6%
Platelet
6%
